Videos

Featured

Babar Basir, Dan Burkhoff, , et al

Giuseppe Rosano, Richard Henry P. Tiongco, Rungroj Krittayaphong, et al

ESC 22: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF &

John JV McMurray,

Watch time: 5:51
ESC 22: MOMENTUM 3: 5-year Results From HeartMate 3 LVAD Therapy

Mandeep Mehra,

Watch time: 7:25
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Watch time: 3:52:31

Stefan Anker, Andrew JS Coats, Shelley Zieroth, et al

Stefan Anker, Andrew JS Coats, Shelley Zieroth, et al

Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29:37

Piotr Ponikowski, Shelley Zieroth, Javed Butler, et al

Watch time: 13.42 (4 videos)

Trending

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Andrew JS Coats, Stefan Anker,

George D Dangas, Adrian P Banning, Davide Cao, et al

Anushka Patel, Stephen Nicholls, Jeffrey Weitz, et al

Giuseppe Rosano, Richard Henry P. Tiongco, Rungroj Krittayaphong, et al

Lars H Lund, James L Januzzi, Justin Ezekowitz, et al

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3:61:38 (47 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Shelley Zieroth, Andrew JS Coats, Javed Butler, et al

Events

Filter by

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF &

John JV McMurray,

Watch time: 5:51
ESC 22: The EMMY Trial: Empagliflozin in Pts with Acute MI

Harald Sourij,

Watch time: 2:55
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22 Late-breaker Discussion: The ADVOR Trial

Harriette Van Spall, Wilfried Mullens,

Watch time: 11:05
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad,

Watch time: 4:44
ESC 22: 3 Trials That Will Change Your Practice With Dr Martha Gulati

Martha Gulati,

Watch time: 7:02
ESC 22 Late-breaker Discussion: The REVIVED Trial

Divaka Perera, Harriette Van Spall,

Watch time: 14:31
ESC 22: MOMENTUM 3: 5-year Results From HeartMate 3 LVAD Therapy

Mandeep Mehra,

Watch time: 7:25
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Latest

Filter by

Babar Basir, Dan Burkhoff, , et al

Giuseppe Rosano, Richard Henry P. Tiongco, Rungroj Krittayaphong, et al

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF &

John JV McMurray,

Watch time: 5:51
ESC 22: The EMMY Trial: Empagliflozin in Pts with Acute MI

Harald Sourij,

Watch time: 2:55
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22 Late-breaker Discussion: The ADVOR Trial

Harriette Van Spall, Wilfried Mullens,

Watch time: 11:05
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad,

Watch time: 4:44